Cases
Cases
Halt Medical’s chapter 11 case, filed on April 12, 2017, was dismissed on May 31, 2019, under the dismissal order Dkt. 268. The case had pursued a sale of assets to Acessa AssetCo LLC, which the court authorized in June 2017; no further case milestone is identified. Sale order Dkt. 125
Halt Medical’s chapter 11 case, filed on April 12, 2017, was dismissed on May 31, 2019, by the dismissal order Dkt. 268. Earlier, the court had authorized a sale of certain assets to Acessa AssetCo LLC under the sale order Dkt. 125. The order establishes authorization of the sale; it does not establish that the transaction closed.
Halt developed the Acessa System to treat uterine fibroids. Its first-day declaration Dkt. 15 attributed the filing to sustained operating losses and a financing shortfall after its principal lender, American Capital, said it would provide no further funding. The declaration reported approximately $66,000 in cash at filing and described a marketing process that led to Acessa AssetCo’s stalking-horse agreement. Calculated funded debt across one instrument was approximately $155,680,599, including accrued interest and fees.
To fund the case and sale process, Halt sought debtor-in-possession financing from Acessa DIPCo LLC; the court granted final authorization in its financing order Dkt. 56.
Updated Nov 5
| Month | Filings |
|---|---|
| April 2017 | 49 |
| May 2017 | 61 |
| June 2017 | 26 |
| July 2017 | 30 |
| August 2017 | 27 |
| September 2017 | 7 |
| October 2017 | 9 |
| November 2017 | 5 |
| December 2017 | 8 |
| January 2018 | 4 |
| February 2018 | 11 |
| March 2018 | 4 |
| April 2018 | 6 |
| May 2018 | 2 |
| June 2018 | 5 |
| July 2018 | 7 |
| August 2018 | 0 |
| September 2018 | 1 |
| October 2018 | 0 |
| November 2018 | 0 |
| December 2018 | 1 |
| January 2019 | 0 |
| February 2019 | 0 |
| March 2019 | 0 |
| April 2019 | 1 |
| May 2019 | 5 |
| June 2019 | 2 |
Case facts and filing dates come from court records.Case docket on PACER